About Malawi CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Malawi CRS
During the past decade, Malawi CRS conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
2003-02-01
2013-11-01
Completed
265
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
2003-06-01
2022-12-22
Completed
588
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
2004-04-01
2016-12-01
Completed
238
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
2005-04-01
Terminated
15
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
2005-11-01
2022-05-20
Completed
940
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
2005-12-01
2022-05-20
Completed
612
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Malawi CRS"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "HIV Prevention Trials Network" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "ViiV Healthcare" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Malawi CRS
According to Clinical.Site data, the most researched conditions in "Malawi CRS" are
"HIV Infections" (10 trials), "Tuberculosis" (4 trials), "COVID-19" (3 trials), "HIV Infection" (3 trials) and "SARS-CoV-2" (2 trials). Many other conditions were trialed in "Malawi CRS" in a lesser frequency.
Clinical Trials Intervention Types at Malawi CRS
Most popular intervention types in "Malawi CRS" are "Drug" (13 trials), "Dietary Supplement" (4 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Isoniazid (INH)" (5 trials), "Rifapentine (RPT)" (4 trials), "VRC01" (3 trials), "Dolutegravir (DTG)" (2 trials) and "Pyrazinamide (PZA)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Malawi CRS
The vast majority of trials in "Malawi CRS" are
14 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Malawi CRS
Currently, there are NaN active trials in "Malawi CRS".
1 are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Malawi CRS,
2 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Malawi CRS, 3 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".